I live with both idiopathic pulmonary hypertension (PH) and scleroderma, and earlier this month, I was taught a lesson in how quickly things can unravel when you’re with people who are well-versed in one condition while you’re dealing with symptoms of the other. I traveled to Washington, D.C., to…
The PHlip-side — Jolie Lizana

Jolie Lizana is a Louisiana woman with a strong sense of hospitality and humor. She was diagnosed 12 years ago with systemic sclerosis, pulmonary hypertension, and heart failure. Jolie advocates for invisible, chronic, and rare diseases, and she is a certified legislative advocate. Her perspective as a former sonographer and EMT breaks barriers between doctors and patients. Jolie volunteers with nonprofits and hosts awareness events. Jolie hopes to bring raw truth and vulnerability to her column.
I lived in a rural area at the time I was diagnosed with pulmonary hypertension (PH). I didn’t meet another PH patient for nearly a year, and even then, we didn’t get to chat because we were both bouncing from one appointment to another. That distance can make an…

I was recently in a pediatrician’s office when I noticed a sticker for Camp Bon Coeur, or “Camp Good Heart.” The camp is in my home state of Louisiana and serves children with heart conditions. It made me think about children with pulmonary hypertension (PH) who can benefit from…
Pulmonary hypertension (PH) is a serious and life-threatening disease. There was a time when the hardest part was simply staying alive, getting through each day, and not knowing what came next. But as my health has improved, the challenges have changed. The hardest part for me now isn’t survival.
I recently went to Washington, D.C., as part of the Pulmonary Hypertension Association’s (PHA) Capitol Hill Day to advocate for the pulmonary hypertension (PH) community and help secure co-sponsorship of the Supplemental Oxygen Access Reform Act (SOAR) and the Safe Step Act. The SOAR Act seeks to reform…
Note: This column describes the author’s own experiences with intravenous therapy. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. When I was diagnosed with pulmonary hypertension (PH), my doctors recommended intravenous (IV) therapy rather than oral medications. They explained…
Nothing I’ve done has helped prepare me for the sudden flashbacks to when I was healthy, active, productive, and all those pretty words my body no longer computes. It happens so suddenly — a gut punch, a reminder of the life I used to have. Almost everything about me has…
Understanding pulmonary hypertension (PH) can be challenging. It’s a complex, unpredictable disease, and explaining it to others can feel daunting. So I’ve put together a quick explainer that may help. Last year, at the Pulmonary Hypertension Association’s (PHA) Capitol Hill Day, I explained PH to many people while…
Comorbidity. Just seeing that word makes me cringe. It means having two or more coexisting, and often chronic, health conditions. For many of us in the rare disease community, comorbidity means additional struggles, headaches, and heartaches. Additionally, too often, comorbidities become a lens through which others see us. Before my…
When I was younger, I created what I call my “time capsule.” I made a point of preserving moments that felt beautiful, thrilling, or special by fully engaging all my senses, while also taking note of my emotions. In those fleeting instances, it felt as if I had frozen time.
There’s something truly rewarding about knowing you’ve helped someone. There is no final goal or checklist to accomplish when that happens — it’s an immediate feeling of success and fulfillment! It’s one way that I, along with others in our PH community, know we are doing meaningful work. As…
My rear end is sore from the gurney, my headache is growing roots thanks to the beaming fluorescent lights, and my chest feels no better than it did when I arrived at the emergency room. So why did I come? After being curled up in my blankets at home for…
Recent Posts
- NDRG1 gene linked to blood vessel scarring in CTEPH: Study
- The importance of connecting with others in the PH community
- Winrevair, prostacyclin therapies work differently to improve PAH outcomes
- New study backs use of blood test checks to aid diagnosis of PAH
- Subtle liver problems may contribute to lung inflammation in PAH: Study
